在神经外科中控制抗卡巴胺耐药生物的多学科基础和捆绑干预
1Department of Hospital Infection Control, Shidong Hospital, Yangpu District, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, 200438, People's Republic of China.
Infection and drug resistance
|February 11, 2025
概括
使用PDCA循环管理的多学科干预措施显著降低了神经外科手术中对卡巴耐药生物体 (CRO) 的检测率. 这种方法有效地控制了这些耐药细菌在二级医院环境中的传播.
科学领域:
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
- 医院流行病学 医院流行病学
背景情况:
- 耐卡巴胺生物体 (CROs) 是由于广泛的耐药性而对公共卫生构成重大威胁.
- 有限的研究存在于二级医院中CRO干预的有效性,特别是在神经外科.
- 需要有效的策略来应对CRO的日益增长的发病率.
研究的目的:
- 评估通过PDCA (计划-做-检查-行动) 周期管理的多学科,捆绑干预措施对控制神经外科手术中CRO的影响.
- 评估这种干预模型在二级医院环境中的有效性.
- 确定影响CRO预防和控制的关键因素.
主要方法:
- 从2021年1月到2023年12月,采用了前后研究设计.
- PDCA循环管理促进了多学科合作和捆绑干预的实施.
- 监测分析和事件分析确定了关键控制点和目标病原体.
主要成果:
- 总的CRO检测率显著下降,从66.45%降至52.25% (RR = 0.786,p < 0.05).
- CRO感染或殖民的发病率密度从每1000个患者日的18.75下降到15.09 (IRR = 0.563,p < 0.05).
- 关键的预防措施,如及时登记和接触预防命令,显示出明显的改善 (p < 0.05).
结论:
- 由PDCA周期指导的多学科和捆绑干预措施在预防和控制神经外科手术中的CRO方面是有效的.
- 这种管理策略表明,它对降低二级医院中CRO患病率产生了积极影响.
- 该PDCA框架支持感染控制实践的持续改进.
相关概念视频
Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Drugs Acting on Autonomic Ganglia: Blockers
1.8K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.8K
Drugs Affecting Neurotransmitter Release or Uptake
1.9K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Drug Therapy
450
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
450


